QUARTER-END POSITION / VERSION 1

BIOMARIN PHARMACEUTICAL INC.

BIOMARIN PHARMACEUTICAL INC

published

Reporting manager: OAKTREE CAPITAL MANAGEMENT LP
Relationship: Associated institution
Record date: 30 Jun 2026
Date meaning: Original Form 13F report period
Quantity: 64,025,000 principal amount
Reported value / amount: $62,373,155
Weight and denominator: 0.87% · Calculated: issuer/class value divided by the complete original reported table; not personal wealth
Quarter-end reported price: Not disclosed · Price at record date, not purchase cost
Derived value per reported unit: $0.9742 · Reported value ÷ reported quantity (principal amount); not an observed market price
Source-reported activity: Not disclosed
Coverage: Complete original information table grouped by CUSIP and security class
Reviewed by: DeepSeek AI
Published: 20 Oct 2026

Original regulatory disclosure; 1 original filing line(s) grouped within this issuer/class. Absence from a disclosed table is not private account verification.

Reporting-entity association: Inspect the identity evidence

Original filing attribution · 1 line(s)

Reporting manager: OAKTREE CAPITAL MANAGEMENT LP. 13F COMBINATION REPORT. These are reported investment-discretion relationships, not proof of beneficial ownership or a personal account. Each original line is counted once, including lines naming multiple managers.

Other included managers: 1 / BROOKFIELD Corp /ON/ · CIK 0001001085; 2 / Oaktree Capital Holdings, LLC · CIK 0001790787.

Managers reporting holdings elsewhere: Russell Investments Group, Ltd. · CIK 0001692234; Hartree Partners, LP · CIK 0001597857. Those other reports are not included in this table’s total.

ORIGINAL LINE	REPORTED QUANTITY / VALUE	OTHER MANAGER / DISCRETION	VOTING AUTHORITY
19	64,025,000 principal amount$62,373,155	BROOKFIELD Corp /ON/ · CIK 0001001085; Oaktree Capital Holdings, LLC · CIK 0001790787Original field: 1,2 · Discretion: DFND	Sole 64,025,000Shared 0 · None 0

View quotation / manual copy ↗

Editorial note: Independent AI source review 2026-10-21T01:14:31+08:00; batch 84ff3bef5309de8f14a7546bb791f49ef2ade43940716054032ffe7e789ec8ba. Original filing quantities, metadata and row attribution checked. Holdings facts only; corporate-action and period comparisons are not reviewed. This is AI review, not a human or private-account audit.

Sources.

Original disclosure

OAKTREE CAPITAL MANAGEMENT LP — 13F-HR — 2026-06-30

U.S. SEC EDGAR · Published 14 Aug 2026 · Collected 20 Oct 2026

Details ↗Open in the source library ↗

Version history.

Version 1published · 20 Oct 2026

Independent AI source review 2026-10-21T01:14:31+08:00; batch 84ff3bef5309de8f14a7546bb791f49ef2ade43940716054032ffe7e789ec8ba. Original filing quantities, metadata and row attribution checked. Holdings facts only; corporate-action and period comparisons are not reviewed. This is AI review, not a human or private-account audit.

Corrections preserve the original record.Suggest a correction ↗

BUILT WITH YOUR INPUT

Your comments help
HoldingsAtlas grow.

Tell us what is useful, what is missing and what we could do better. Your feedback matters.

Visit the feedback page ↗

Copy a dated citation.

English factual summary

OAKTREE CAPITAL MANAGEMENT LP reported 64,025,000 principal amount of BIOMARIN PHARMACEUTICAL INC as of 2026-06-30. Reported value: $62,373,155. Weight: 0.87% of Calculated: issuer/class value divided by the complete original reported table; not personal wealth. This is a dated quarter-end position, not a live position, purchase cost or the associated person’s personal account. Filing type: 13F COMBINATION REPORT. Original rows also reference these included managers: BROOKFIELD Corp /ON/; Oaktree Capital Holdings, LLC. Manager references describe reported investment discretion, not beneficial ownership. Some holdings are reported elsewhere by Russell Investments Group, Ltd.; Hartree Partners, LP and are outside this table.
Source: U.S. SEC EDGAR — https://www.sec.gov/Archives/edgar/data/949509/000094950926000005/13F_OCMLP_2Q2026.xml | Published: 2026-08-14 | Collected: 2026-10-20T16:20:56.797Z
Record: https://holdingsatlas.com/records/32d1685c-4fa0-4224-9c11-6384b34feeaa/

If copying is unavailable, select the text above and copy it manually.